Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mylotarg and Chemotherapy in De Novo AML
NCT01698879Phase 2Completed
- Start
- Oct 2009
- Primary completion
- Sep 2016
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemtuzumab ozogamicin in acute myeloid leukemia (AML). Started Oct 2009; status: completed.
02
Drugs
gemtuzumab ozogamicin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01698879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698879.